Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

GlobeNewswireNov 21 16:30 ET

Kane Biotech Announces Health Canada Approval of Revyve Antimicrobial Wound Gel

GlobeNewswireNov 14 13:10 ET

Kane Biotech Announces Agreement to Acquire FB Dermatology

GlobeNewswireNov 12 13:08 ET

Kane Biotech Donates Antimicrobial Wound Gel to Ukraine

MT NewswiresOct 23 09:09 ET

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

GlobeNewswireOct 17 08:30 ET

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

GlobeNewswireOct 3 08:30 ET